The neurological disease therapy developer had raised about $57m from investors including Alphabet, Johnson & Johnson and Biogen.

Cancer data platform operator MedBanks raised the capital in a series D-plus round led by Tencent, also a contributor to its series D in January.

Home diagnostics test provider Healthians collected $11.8m from investors including two Digital Garage vehicles to help broaden its technology, services and geographical presence.

Corporate venturing unit Johnson & Johnson Innovation – JJDC has appointed Chris Picariello president following the retirement of Tom Heyman.

UAVenture Capital Fund II has backed University of Arizona spinout StimAire, which is working on neuromodulation-based treatments for conditions including obstructive sleep apnoea.

Toppan Printing, Mitsui Sumitomo Insurance, Elan Corporation and CBC Co all invested in a $15.6m round for medical suppliers e-commerce platform Medikabazaar.

Smoking cessation service Carrot has hired Busy Burr as president and CEO, months after she left Humana after setting up its corporate venturing arm.

The fibrotic disease drug developer, which had raised $50m from investors including Shire, will be bought for $390m upfront and up to $1bn in milestone payments.

The drug discovery startup, co-founded by research technology producer Atomwise, has pulled in $14.5m through a round led by DCVC Bio.

Each Friday, the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.